CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


<
Enzo Biochem Inc  (ENZ)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
 


 

Enzo Biochem Inc

ENZ's Financial Statements and Analysis




Enzo Biochem Inc reported break-eaven for the III. Quarter compare to net loss per share of $-0.05 recorded in the same quarter a year ago an improvement compare to $-0.02 realized in previous quarter.

Enzo Biochem Inc's Revenue rose by % in III. Quarter (Apr 30 2017) year on year, to $27 million and advanced by 3.16 % sequentially.


Enzo Biochem Inc is
More on ENZ's Income Statement

III. Quarter
Earnings Per Share Revenues
$ 0 $  27 Mill
$+0.05     $+1M     +2.48 %
You need to upgrade your Flash Player
ENZ's NET INCOME

Enzo Biochem Inc's in III. Quarter recorded net loss of $-0 million, an improvement compare to net loss of $-2 million in III. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-1.05 million realized in previous quarter.

More on ENZ's Growth

Inventories Inventories grew by 2.75 % to $7 million from III. Quarter a year ago, sequentially inventories rose by 0.77 %. ENZ's Cash flow In III. Quarter company's net cash flow was $0 million, capital expenditures fell by 64.80%, to $-1 millions compare to same quarter a year ago and fell by 320.00% from II. Quarter (Jan 31 2017).

More on ENZ's Cash flow Statement



Enzo Biochem Inc does not pay out common stock dividend.

In trailing twelve-month period Enzo Biochem Inc earned $ 0.74 cash per share, on a free-cash flow basis 103.54 % of net earning per share.

Book value grew by 0.79 % sequentially to $1.91 per share, 107.42% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 1.68 per share from $ 1.66.

Company issued 0.07 million shares or 0.16 % in III. Quarter.
Debt Coverage Ratio was 38.88.

More on ENZ's Dividends
 Market Capitalization (Millions) 526
 Shares Outstanding (Millions) 46
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 106
 Net Income (TTM) (Millions $) 34
 Cash Flow (TTM) (Millions $) 30
 Capital Exp. (TTM) (Millions $) -2
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -


   



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com